As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of HilleVax, Inc. - Common Stock (HLVX). This represents 0% of the company’s total 49,862,069 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$82,473,243 | $2.09 | 0 |
| 2025 Q2 | 41,482,960 | $82,475,168 | -$1,289,603 | $1.99 | 73 |
| 2025 Q1 | 42,159,649 | $61,462,292 | -$803,639 | $1.45 | 81 |
| 2024 Q4 | 42,837,211 | $88,691,128 | -$1,922,828 | $2.07 | 76 |
| 2024 Q3 | 41,746,872 | $73,514,520 | -$125,351,237 | $1.76 | 79 |
| 2024 Q2 | 38,767,553 | $560,388,196 | +$17,186,329 | $14.46 | 90 |
| 2024 Q1 | 43,902,279 | $730,023,202 | +$33,987,539 | $16.63 | 80 |
| 2023 Q4 | 6,734,335 | $108,086,477 | +$165,877 | $16.05 | 2 |
| 2023 Q3 | 34,134,471 | $459,257,505 | +$117,952,603 | $13.45 | 68 |
| 2023 Q2 | 25,405,469 | $436,645,669 | -$15,432,146 | $17.19 | 54 |
| 2023 Q1 | 26,409,127 | $436,247,374 | +$31,739,638 | $16.53 | 61 |
| 2022 Q4 | 26,312,441 | $440,206,772 | +$21,737,952 | $16.73 | 55 |
| 2022 Q3 | 23,399,373 | $399,913,116 | -$7,526,386 | $17.09 | 50 |
| 2022 Q2 | 23,224,867 | $253,676,000 | +$253,676,233 | $10.93 | 54 |